Key statistics
As of last trade Virbac SA (V16:FRA) traded at 355.00, -3.53% below its 52-week high of 368.00, set on Jan 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 351.00 |
|---|---|
| High | 355.00 |
| Low | 351.00 |
| Bid | 352.50 |
| Offer | 366.50 |
| Previous close | 355.00 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 8.39m |
| Free float | 4.13m |
| P/E (TTM) | 22.64 |
| Market cap | 3.02bn EUR |
| EPS (TTM) | 15.88 EUR |
| Annual div (ADY) | 1.45 EUR |
|---|---|
| Annual div yield (ADY) | 0.41% |
| Div ex-date | Jun 24 2025 |
| Div pay-date | Jun 26 2025 |
Data delayed at least 15 minutes, as of Feb 13 2026 14:25 GMT.
More ▼
Announcements
- Virbac : Déclaration d'actions et de droits de vote 01/2026
- Virbac : Declaration of the number of shares and voting rights 01/2026
- Virbac: solide croissance en 2025 avec un chiffre d'affaires annuel en hausse de +7,9 % à pcc3, forte dynamique dans les catégories et pays clés
- Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries
- Virbac : Déclaration d'actions et de droits de vote 12/2025
- Virbac : Declaration of the number of shares and voting rights 12/2025
- VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm
- VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
- Virbac : Declaration of the number of shares and voting rights 11/2025
- Virbac : Déclaration d'actions et de droits de vote 11/2025
More ▼
